SEC Form 4 · accession 0001624073-16-000009
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alistair Macdonald
Officer — Chief Operating Officer
Period of report
Jul 11, 2016
Accepted (ET)
Jul 12, 2016 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jul 11, 2016 | M | 9,468 | $16.06 | A | 28,144 | D | |
| Class A Common StockF2 | Jul 11, 2016 | S | 9,468 | $40.188 | D | 18,676 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $16.06 | Jul 11, 2016 | M | 9,468 | D | — | Jun 30, 2024 | Class A Common Stock | 9,468 | 56,802 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2015.
- F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.39, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3One half of the shares subject to this option vest yearly in five equal installments beginning on June 30, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.